{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:23:05Z","timestamp":1785554585403,"version":"3.56.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ebiom.2024.105108","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T20:03:34Z","timestamp":1713816214000},"page":"105108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Impacts of gene variants on drug effects-the foundation of genotype-guided pharmacologic therapy for long QT syndrome and short QT syndrome"],"prefix":"10.1016","volume":"103","author":[{"given":"Zhihan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobiao","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerun","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"M\u00fcgge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assem","family":"Aweimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3053-0008","authenticated-orcid":false,"given":"Nazha","family":"Hamdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5895-0127","authenticated-orcid":false,"given":"Xiaobo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Akin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"El-Battrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ebiom.2024.105108_bib1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jacep.2022.02.017","article-title":"Congenital long QT syndrome","volume":"8","author":"Krahn","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib2","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1038\/s41598-022-06835-y","article-title":"A\u00a0descriptive report on short QT interval in Kherameh branch of the Persian cohort study","volume":"12","author":"Nikoo","year":"2022","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105108_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/toxsci\/kfy299","article-title":"Evaluation of possible proarrhythmic potency: comparison of the effect of dofetilide, cisapride, sotalol, terfenadine, and verapamil on hERG and native IKr currents and on cardiac action potential","volume":"168","author":"Orvos","year":"2019","journal-title":"Toxicol Sci"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105108_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/bjp.2008.325","article-title":"Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs","volume":"155","author":"McPate","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105108_bib5","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jacc.2004.02.034","article-title":"Short QT syndrome: pharmacological treatment","volume":"43","author":"Gaita","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105108_bib6","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/cpt.1449","article-title":"Drug testing in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with\u00a0short QT syndrome type 1","volume":"106","author":"Zhao","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ebiom.2024.105108_bib7","article-title":"Effects of antiarrhythmic drugs on hERG gating in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with short QT syndrome type 1","volume":"12","author":"Huang","year":"2021","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105108_bib8","first-page":"962","article-title":"Short QT syndrome: the current evidences of diagnosis and management","volume":"36","author":"Dewi","year":"2020","journal-title":"J\u00a0Arrhythm"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105108_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000359995","article-title":"Short QT syndrome: a predictable story","volume":"128","author":"Brugada","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/j.ebiom.2024.105108_bib10","article-title":"ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"2022","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105108_bib11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/europace\/euab214","article-title":"Preclinical short QT syndrome models: studying the phenotype and drug-screening","volume":"24","author":"Fan","year":"2022","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib12","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/s41467-017-01630-0","article-title":"Loss-of-activity-mutation in the cardiac chloride-bicarbonate exchanger AE3 causes short QT syndrome","volume":"8","author":"Thorsen","year":"2017","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105108_bib13","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.hrthm.2023.02.010","article-title":"Genetic analysis identifies the SLC4A3 anion exchanger as a major gene for short QT syndrome","volume":"20","author":"Christiansen","year":"2023","journal-title":"Heart Rhythm"},{"issue":"15","key":"10.1016\/j.ebiom.2024.105108_bib14","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehab687","article-title":"Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death","volume":"43","author":"Walsh","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ebiom.2024.105108_bib15","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3389\/fphar.2019.01572","article-title":"An update on the structure of hERG","volume":"10","author":"Butler","year":"2019","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105108_bib16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.yjmcc.2010.11.017","article-title":"A\u00a0novel mutation in the KCNH2 gene associated with short QT syndrome","volume":"50","author":"Sun","year":"2011","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijcard.2008.05.050","article-title":"A\u00a0novel KCNH2 mutation as a modifier for short QT interval","volume":"137","author":"Itoh","year":"2009","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105108_bib18","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/S0828-282X(09)70077-7","article-title":"Rapid genetic testing facilitating the diagnosis of short QT syndrome","volume":"25","author":"Redpath","year":"2009","journal-title":"Can J Cardiol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105108_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01429","article-title":"Functional and pharmacological characterization of an S5 domain hERG mutation associated with short QT syndrome","volume":"5","author":"Butler","year":"2019","journal-title":"Heliyon"},{"issue":"Fi1","key":"10.1016\/j.ebiom.2024.105108_bib20","doi-asserted-by":"crossref","first-page":"f113","DOI":"10.1093\/europace\/eux186","article-title":"Multiple clinical profiles of families with the short QT syndrome","volume":"20","author":"Akdis","year":"2018","journal-title":"Europace"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105108_bib21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jacep.2016.11.013","article-title":"The phenotypic spectrum of a mutation hotspot responsible for the short QT syndrome","volume":"3","author":"Hu","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"issue":"20","key":"10.1016\/j.ebiom.2024.105108_bib22","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/01.CIR.0000130409.72142.FE","article-title":"Mutation in the KCNQ1 gene leading to the short QT-interval syndrome","volume":"109","author":"Bellocq","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105108_bib23","first-page":"394","article-title":"Characterization of a Chinese KCNQ1 mutation (R259H) that shortens repolarization and causes short QT syndrome 2","volume":"12","author":"Wu","year":"2015","journal-title":"J\u00a0Geriatr Cardiol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105108_bib24","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/cvr\/cvv196","article-title":"A\u00a0new KCNQ1 mutation at the S5 segment that impairs its association with KCNE1 is responsible for short QT syndrome","volume":"107","author":"Moreno","year":"2015","journal-title":"Cardiovasc Res"},{"issue":"1879","key":"10.1016\/j.ebiom.2024.105108_bib25","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2022.0165","article-title":"Pro-arrhythmic effects of gain-of-function potassium channel mutations in the short QT syndrome","volume":"378","author":"Hancox","year":"2023","journal-title":"Phil Trans Roy Soc Lond B Biol Sci"},{"key":"10.1016\/j.ebiom.2024.105108_bib26","article-title":"Investigation of the effects of the short QT syndrome D172N Kir 2.1 mutation on ventricular action potential profile using dynamic clamp","volume":"12","author":"Du","year":"2021","journal-title":"Front Pharmacol"},{"issue":"16","key":"10.1016\/j.ebiom.2024.105108_bib27","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/CIRCULATIONAHA.120.050098","article-title":"MicroRNA biophysically modulates cardiac action potential by direct binding to Ion channel","volume":"143","author":"Yang","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ebiom.2024.105108_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7194275","article-title":"Computational study to identify the effects of the KCNJ2 E299V mutation in cardiac pumping capacity","volume":"2020","author":"Jeong","year":"2020","journal-title":"Comput Math Methods Med"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105108_bib29","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1161\/CIRCULATIONAHA.106.668392","article-title":"Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death","volume":"115","author":"Antzelevitch","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12967-017-1203-y","article-title":"Erratum to: novel trigenic CACNA1C\/DES\/MYPN mutations in a family of hypertrophic cardiomyopathy with early repolarization and short QT syndrome","volume":"15","author":"Chen","year":"2017","journal-title":"J\u00a0Transl Med"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105108_bib31","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/eurheartj\/ehr076","article-title":"Identification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6)","volume":"32","author":"Templin","year":"2011","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105108_bib32","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/ejhg.2012.63","article-title":"Concomitant Brugada-like and short QT electrocardiogram linked to SCN5A mutation","volume":"20","author":"Hong","year":"2012","journal-title":"Eur J Hum Genet"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105108_bib33","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/jce.12173","article-title":"Characterization of 2 genetic variants of Na(v) 1.5-arginine 689 found in patients with cardiac arrhythmias","volume":"24","author":"Sottas","year":"2013","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.CIR.0000109482.92774.3A","article-title":"Sudden death associated with short-QT syndrome linked to mutations in HERG","volume":"109","author":"Brugada","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105108_bib35","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.yjmcc.2006.05.021","article-title":"Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome","volume":"41","author":"McPate","year":"2006","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105108_bib36","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1111\/j.1540-8167.2012.02292.x","article-title":"Nifekalant enlarged the transmural activation-recovery interval difference as well as the peak-to-end interval on surface ECG in a patient with short-QT syndrome","volume":"23","author":"Chinushi","year":"2012","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105108_bib37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.hrcr.2015.07.001","article-title":"The lack of effect of sotalol in short QT syndrome patients carrying the T618I mutation in the KCNH2 gene","volume":"1","author":"Giustetto","year":"2015","journal-title":"HeartRhythm Case Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1540-8167.2005.04470.x","article-title":"Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG","volume":"16","author":"Wolpert","year":"2005","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105108_bib39","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/jce.12178","article-title":"Differential effects of the \u03b2-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels","volume":"24","author":"Bodi","year":"2013","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105108_bib40","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/jce.13029","article-title":"Ranolazine and vernakalant prevent ventricular arrhythmias in an experimental whole-heart model of short QT syndrome","volume":"27","author":"Frommeyer","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"7","key":"10.1016\/j.ebiom.2024.105108_bib41","article-title":"Modeling short QT syndrome using human-induced pluripotent stem cell-derived cardiomyocytes","volume":"7","author":"El-Battrawy","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"18","key":"10.1016\/j.ebiom.2024.105108_bib42","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.jacc.2019.02.055","article-title":"Modeling reentry in the short QT syndrome with human-induced pluripotent stem cell-derived cardiac cell sheets","volume":"73","author":"Shinnawi","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ebiom.2024.105108_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.yjmcc.2023.08.003","article-title":"Utilizing human induced pluripotent stem cells to study atrial arrhythmias in the short QT syndrome","volume":"183","author":"Shiti","year":"2023","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.ebiom.2024.105108_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.554422","article-title":"Ionic mechanisms of disopyramide prolonging action potential duration in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with short QT syndrome type 1","volume":"11","author":"Lan","year":"2020","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105108_bib45","article-title":"Antiarrhythmic effects of vernakalant in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with short QT syndrome type 1","volume":"9","author":"Xu","year":"2022","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105108_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008089","article-title":"Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes","volume":"17","author":"J\u00e6ger","year":"2021","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.ebiom.2024.105108_bib47","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3389\/fphys.2018.01402","article-title":"Human atrial arrhythmogenesis and sinus bradycardia in KCNQ1-linked short QT syndrome: insights from computational modelling","volume":"9","author":"Whittaker","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.ebiom.2024.105108_bib48","first-page":"4273","article-title":"Modeling the effects of amiodarone on short QT syndrome variant 2 in the human ventricles","volume":"2017","author":"Cunjin","year":"2017","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105108_bib49","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/aps.2017.86","article-title":"Therapeutic effects of a taurine-magnesium coordination compound on experimental models of type 2 short QT syndrome","volume":"39","author":"An","year":"2018","journal-title":"Acta Pharmacol Sin"},{"issue":"24","key":"10.1016\/j.ebiom.2024.105108_bib50","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.jacc.2017.10.025","article-title":"Hydroquinidine prevents life-threatening arrhythmic events in patients with short QT syndrome","volume":"70","author":"Mazzanti","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105108_bib51","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/cvr\/cvr008","article-title":"Structural bases for the different anti-fibrillatory effects of chloroquine and quinidine","volume":"89","author":"Noujaim","year":"2011","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105108_bib52","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.yjmcc.2009.02.027","article-title":"Action potential clamp and chloroquine sensitivity of mutant Kir2.1 channels responsible for variant 3 short QT syndrome","volume":"47","author":"El Harchi","year":"2009","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"23","key":"10.1016\/j.ebiom.2024.105108_bib53","doi-asserted-by":"crossref","first-page":"15432","DOI":"10.1074\/jbc.M901586200","article-title":"Specific and slow inhibition of the kir2.1 K+ channel by gambogic acid","volume":"284","author":"Zaks-Makhina","year":"2009","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12938-017-0369-0","article-title":"Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study","volume":"16","author":"Luo","year":"2017","journal-title":"Biomed Eng Online"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105108_bib55","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1088\/1361-6579\/aa8695","article-title":"Modelling the effects of quinidine, disopyramide, and E-4031 on short QT syndrome variant 3 in the human ventricles","volume":"38","author":"Luo","year":"2017","journal-title":"Physiol Meas"},{"key":"10.1016\/j.ebiom.2024.105108_bib56","first-page":"5462","article-title":"Computational analysis of the action of chloroquine on short QT syndrome variant 1 and variant 3 in human ventricles","volume":"2018","author":"Luo","year":"2018","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib57","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/19336950.2016.1207022","article-title":"Styrax blocks inward and outward current of Kir 2.1 channel","volume":"11","author":"Ren","year":"2017","journal-title":"Channels"},{"key":"10.1016\/j.ebiom.2024.105108_bib58","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3389\/fphar.2019.00771","article-title":"Impact of antiarrhythmic drugs on the outcome of short QT syndrome","volume":"10","author":"El-Battrawy","year":"2019","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105108_bib59","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1002\/ctm2.646","article-title":"Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene-edited human-induced pluripotent stem cell-derived cardiomyocytes and preclinical drug screening","volume":"11","author":"El-Battrawy","year":"2021","journal-title":"Clin Transl Med"},{"issue":"15","key":"10.1016\/j.ebiom.2024.105108_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158313","article-title":"A\u00a0preclinical study on brugada syndrome with a CACNB2 variant using human cardiomyocytes from induced pluripotent stem cells","volume":"23","author":"Zhong","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"13","key":"10.1016\/j.ebiom.2024.105108_bib61","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/eurheartj\/ehab070","article-title":"Different genotypes of Brugada syndrome may present different clinical phenotypes: electrophysiology from bench to bedside","volume":"42","author":"El-Battrawy","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105108_bib62","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/heartjnl-2020-318259","article-title":"Diagnosis, management and therapeutic strategies for congenital long QT syndrome","volume":"108","author":"Wilde","year":"2022","journal-title":"Heart"},{"issue":"14","key":"10.1016\/j.ebiom.2024.105108_bib63","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105108_bib64","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCULATIONAHA.119.043132","article-title":"An international, multicentered, evidence-based reappraisal of genes reported to cause congenital long QT syndrome","volume":"141","author":"Adler","year":"2020","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105108_bib65","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cpcardiol.2013.08.001","article-title":"Genotype- and phenotype-guided management of congenital long QT syndrome","volume":"38","author":"Giudicessi","year":"2013","journal-title":"Curr Probl Cardiol"},{"issue":"13","key":"10.1016\/j.ebiom.2024.105108_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137389","article-title":"Mutation-specific differences in Kv7.1 (KCNQ1) and Kv11.1 (KCNH2) channel dysfunction and long QT syndrome phenotypes","volume":"23","author":"Kekenes-Huskey","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2024.105108_bib67","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-981-16-4254-8_15","article-title":"Physiological functions, biophysical properties, and regulation of KCNQ1 (K(V)7.1) potassium channels","volume":"1349","author":"Sanguinetti","year":"2021","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105108_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/biom10081144","article-title":"Long QT syndrome type 2: emerging strategies for correcting class 2 KCNH2 (hERG) mutations and identifying new patients","volume":"10","author":"Ono","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.2079","article-title":"Same family, same mutation, different ECG","volume":"11","author":"Akbu\u011fa","year":"2023","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105108_bib70","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.hrthm.2020.08.017","article-title":"Long QT syndrome type 1 and 2 patients respond differently to arrhythmic triggers: the TriQarr in\u00a0vivo study","volume":"18","author":"Marstrand","year":"2021","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96474-6","article-title":"Na(V)1.5 knockout in iPSCs: a novel approach to study Na(V)1.5 variants in a human cardiomyocyte environment","volume":"11","author":"Pierre","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib72","article-title":"Analysis of the shape of the T-wave in congenital long-QT syndrome type 3 by geometric morphometrics","volume":"11","author":"Horigome","year":"2021","journal-title":"Sci Rep"},{"issue":"20","key":"10.1016\/j.ebiom.2024.105108_bib73","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jacc.2012.07.046","article-title":"Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol","volume":"60","author":"Chockalingam","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.ebiom.2024.105108_bib74","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2014.05.068","article-title":"Efficacy of different beta-blockers in the treatment of long QT syndrome","volume":"64","author":"Abu-Zeitone","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105108_bib75","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10840-016-0161-2","article-title":"Experience with bisoprolol in long-QT1 and long-QT2 syndrome","volume":"47","author":"Steinberg","year":"2016","journal-title":"J\u00a0Intervent Card Electrophysiol"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105108_bib76","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.007280","article-title":"Mexiletine shortens the QT interval in patients with potassium channel-mediated type 2 long QT syndrome","volume":"12","author":"Bos","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105108_bib77","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jccase.2020.07.007","article-title":"Subcutaneous and transvenous implantable cardioverter defibrillator in high-risk long-QT syndrome type 3 associated with Val411Met mutation in SCN5A","volume":"22","author":"Yokoyama","year":"2020","journal-title":"J\u00a0Cardiol Cases"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105108_bib78","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with\u00a0long\u00a0QT syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105108_bib79","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1540-8167.2008.01246.x","article-title":"Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome","volume":"19","author":"Moss","year":"2008","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"14","key":"10.1016\/j.ebiom.2024.105108_bib80","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1161\/01.CIR.101.14.1698","article-title":"Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome?","volume":"101","author":"Benhorin","year":"2000","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105108_bib81","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.hrthm.2006.04.024","article-title":"Verapamil decreases ventricular tachyarrhythmias in a patient with Timothy syndrome (LQT8)","volume":"3","author":"Jacobs","year":"2006","journal-title":"Heart Rhythm"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105108_bib82","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00392-011-0358-4","article-title":"A\u00a0rare association of long QT syndrome and syndactyly: timothy syndrome (LQT 8)","volume":"100","author":"Krause","year":"2011","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105108_bib83","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/FJC.0b013e318203a44d","article-title":"Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbits","volume":"57","author":"Bentzen","year":"2011","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105108_bib84","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/europace\/euab228","article-title":"Docosahexaenoic acid normalizes QT interval in long QT type 2 transgenic rabbit models in a genotype-specific fashion","volume":"24","author":"Castiglione","year":"2022","journal-title":"Europace"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105108_bib85","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jacc.2009.10.033","article-title":"Late na(+) current inhibition by ranolazine reduces torsades de pointes in the chronic atrioventricular block dog model","volume":"55","author":"Antoons","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib86","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0026-895X(24)26447-6","article-title":"Preferential block of late sodium current in the LQT3 DeltaKPQ mutant by the class I(C) antiarrhythmic flecainide","volume":"57","author":"Nagatomo","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ebiom.2024.105108_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2020.04.027","article-title":"A\u00a0distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant","volume":"144","author":"Gando","year":"2020","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"7337","key":"10.1016\/j.ebiom.2024.105108_bib88","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature09747","article-title":"Modelling the long QT syndrome with induced pluripotent stem cells","volume":"471","author":"Itzhaki","year":"2011","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105108_bib89","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/eurheartj\/ehr073","article-title":"Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation","volume":"32","author":"Matsa","year":"2011","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105108_bib90","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00395-016-0530-0","article-title":"Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction","volume":"111","author":"Malan","year":"2016","journal-title":"Basic Res Cardiol"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105108_bib91","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1213\/ANE.0b013e3182323245","article-title":"Bupivacaine destabilizes action potential duration in cellular and computational models of long QT syndrome 1","volume":"113","author":"Schwoerer","year":"2011","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib92","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.hrthm.2012.09.124","article-title":"RNA interference targeting E637K mutation rescues hERG channel currents and restores its kinetic properties","volume":"10","author":"Lu","year":"2013","journal-title":"Heart Rhythm"},{"issue":"4 Suppl","key":"10.1016\/j.ebiom.2024.105108_bib93","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1542-474X.2005.00077.x","article-title":"Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial","volume":"10","author":"Moss","year":"2005","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105108_bib94","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1111\/j.1540-8159.2010.02913.x","article-title":"Ranolazine safely decreases ventricular and atrial fibrillation in Timothy syndrome (LQT8)","volume":"35","author":"Shah","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib95","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41598-017-00413-3","article-title":"Inhibition of serum and glucocorticoid regulated kinase-1 as novel therapy for cardiac arrhythmia disorders","volume":"7","author":"Bezzerides","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105108_bib96","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.hrthm.2022.12.036","article-title":"SGK1 inhibition attenuates the action potential duration in reengineered heart cell models of drug-induced QT prolongation","volume":"20","author":"Kim","year":"2023","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105108_bib97","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad094","article-title":"Gene- and variant-specific efficacy of serum\/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2","volume":"25","author":"Giannetti","year":"2023","journal-title":"Europace"},{"issue":"22","key":"10.1016\/j.ebiom.2024.105108_bib98","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1161\/CIRCULATIONAHA.121.053350","article-title":"Cardiac late sodium channel current is a molecular target for the sodium\/glucose cotransporter 2 inhibitor empagliflozin","volume":"143","author":"Philippaert","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib99","doi-asserted-by":"crossref","first-page":"53","DOI":"10.33963\/KP.15666","article-title":"Empagliflozin significantly attenuates sotalol-induced QTc prolongation in rats","volume":"79","author":"\u00d6zg\u00fcr","year":"2021","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.ebiom.2024.105108_bib100","first-page":"1","article-title":"Empagliflozin significantly prevents QTc prolongation due to amitriptyline intoxication","volume":"34","author":"Bar\u0131\u015f","year":"2023","journal-title":"Cardiovasc J Afr"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105108_bib101","first-page":"626","article-title":"Effects of SGLT2 inhibitors as an add-on therapy to metformin on electrocardiographic indices of ventricular repolarization","volume":"36","author":"Duran","year":"2020","journal-title":"Acta Cardiol Sin"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib102","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-5793(97)01245-3","article-title":"Modulation of HERG affinity for E-4031 by [K+]o and C-type inactivation","volume":"417","author":"Wang","year":"1997","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.ebiom.2024.105108_bib103","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.RES.82.3.386","article-title":"Molecular determinants of dofetilide block of HERG K+ channels","volume":"82","author":"Ficker","year":"1998","journal-title":"Circ Res"},{"issue":"11","key":"10.1016\/j.ebiom.2024.105108_bib104","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.RES.87.11.1012","article-title":"Probing the interaction between inactivation gating and Dd-sotalol block of HERG","volume":"87","author":"Numaguchi","year":"2000","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.ebiom.2024.105108_bib105","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0026-895X(24)23209-0","article-title":"Molecular determinant of high-affinity dofetilide binding to HERG1 expressed in Xenopus oocytes: involvement of S6 sites","volume":"57","author":"Lees-Miller","year":"2000","journal-title":"Mol Pharmacol"},{"issue":"22","key":"10.1016\/j.ebiom.2024.105108_bib106","doi-asserted-by":"crossref","first-page":"11996","DOI":"10.1073\/pnas.97.22.11996","article-title":"Molecular spectroscopy and dynamics of intrinsically fluorescent proteins: coral red (dsRed) and yellow (Citrine)","volume":"97","author":"Heikal","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105108_bib107","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1161\/01.RES.84.9.989","article-title":"Mechanism of block and identification of the verapamil binding domain to HERG potassium channels","volume":"84","author":"Zhang","year":"1999","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105108_bib108","first-page":"554","article-title":"Inactivation gating determines drug potency: a common mechanism for drug blockade of HERG channels","volume":"25","author":"Yang","year":"2004","journal-title":"Acta Pharmacol Sin"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105108_bib109","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/CIRCRESAHA.118.314050","article-title":"Predicting patient response to the antiarrhythmic mexiletine based on genetic variation","volume":"124","author":"Zhu","year":"2019","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105108_bib110","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/CIRCULATIONAHA.107.707877","article-title":"Gating properties of SCN5A mutations and the response to mexiletine in long-QT syndrome type 3 patients","volume":"116","author":"Ruan","year":"2007","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105108_bib111","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1161\/hc3501.093797","article-title":"Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes","volume":"104","author":"Viswanathan","year":"2001","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105108_bib112","doi-asserted-by":"crossref","DOI":"10.3390\/biology10101062","article-title":"Induced pluripotent stem cell-derived cardiomyocytes with SCN5A R1623Q mutation associated with severe long QT syndrome in fetuses and neonates recapitulates pathophysiological phenotypes","volume":"10","author":"Hayama","year":"2021","journal-title":"Biology"},{"key":"10.1016\/j.ebiom.2024.105108_bib113","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3389\/fphar.2020.01182","article-title":"Gating properties of mutant sodium channels and responses to sodium current inhibitors predict mexiletine-sensitive mutations of long QT syndrome 3","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib114","doi-asserted-by":"crossref","first-page":"H288","DOI":"10.1152\/ajpheart.00539.2010","article-title":"Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav 1.5 channels","volume":"300","author":"Huang","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105108_bib115","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.hrthm.2023.01.032","article-title":"Functional characterization and identification of a therapeutic for a novel SCN5A-F1760C variant causing type 3 long QT syndrome refractory to all guideline-directed therapies","volume":"20","author":"Stutzman","year":"2023","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib116","article-title":"Characterization of a novel LQT3 variant with a selective efficacy of mexiletine treatment","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ebiom.2024.105108_bib117","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1016\/j.ijcard.2013.08.015","article-title":"Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells","volume":"168","author":"Ma","year":"2013","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.ebiom.2024.105108_bib118","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1253\/circj.CJ-13-1167","article-title":"Flecainide provocation reveals concealed brugada syndrome in a long QT syndrome family with a novel L1786Q mutation in SCN5A","volume":"78","author":"Kanters","year":"2014","journal-title":"Circ J"},{"issue":"Pt 1","key":"10.1016\/j.ebiom.2024.105108_bib119","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1113\/jphysiol.2004.065003","article-title":"State-dependent trapping of flecainide in the cardiac sodium channel","volume":"560","author":"Ramos","year":"2004","journal-title":"J\u00a0Physiol"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/19336950.2018.1475794","article-title":"Mexiletine rescues a mixed biophysical phenotype of the cardiac sodium channel arising from the SCN5A mutation, N406K, found in LQT3 patients","volume":"12","author":"Hu","year":"2018","journal-title":"Channels"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib121","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1085\/jgp.201210899","article-title":"Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics","volume":"141","author":"Terrenoire","year":"2013","journal-title":"J\u00a0Gen Physiol"},{"issue":"12","key":"10.1016\/j.ebiom.2024.105108_bib122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001258","article-title":"A\u00a0novel and lethal de novo LQT-3 mutation in a newborn with distinct molecular pharmacology and therapeutic response","volume":"2","author":"Bankston","year":"2007","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ebiom.2024.105108_bib123","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/ALN.0000000000000583","article-title":"Enhanced effects of isoflurane on the long QT syndrome 1-associated A341V mutant","volume":"122","author":"Mikuni","year":"2015","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib124","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1038\/s41598-018-22033-1","article-title":"The efficacy of Ranolazine on E1784K is altered by temperature and calcium","volume":"8","author":"Abdelsayed","year":"2018","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105108_bib125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184605","article-title":"Depolarization of the conductance-voltage relationship in the NaV1.5 mutant, E1784K, is due to altered fast inactivation","volume":"12","author":"Peters","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ebiom.2024.105108_bib126","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1073\/pnas.1114748109","article-title":"Crystallographic basis for calcium regulation of sodium channels","volume":"109","author":"Sarhan","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"33","key":"10.1016\/j.ebiom.2024.105108_bib127","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2025320118","article-title":"Functional cross-talk between phosphorylation and disease-causing mutations in the cardiac sodium channel Na(v)1.5","volume":"118","author":"Galleano","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"25","key":"10.1016\/j.ebiom.2024.105108_bib128","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1161\/01.CIR.0000070936.65183.97","article-title":"Stimulation of protein kinase C inhibits bursting in disease-linked mutant human cardiac sodium channels","volume":"107","author":"Tateyama","year":"2003","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ebiom.2024.105108_bib129","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCRESAHA.110.218891","article-title":"Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3","volume":"106","author":"Ruan","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.ebiom.2024.105108_bib130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejphar.2014.09.028","article-title":"Electrophysiological and trafficking defects of the SCN5A T353I mutation in Brugada syndrome are\u00a0rescued by alpha-allocryptopine","volume":"746","author":"Zhang","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ebiom.2024.105108_bib131","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.902224","article-title":"Pharmacological rescue of specific long QT variants of KCNQ1\/KCNE1 channels","volume":"13","author":"Zou","year":"2022","journal-title":"Front Physiol"},{"issue":"10","key":"10.1016\/j.ebiom.2024.105108_bib132","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1161\/01.RES.0000102866.67863.2B","article-title":"Pharmacological activation of normal and arrhythmia-associated mutant KCNQ1 potassium channels","volume":"93","author":"Seebohm","year":"2003","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.ebiom.2024.105108_bib133","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/mol.54.1.220","article-title":"A novel benzodiazepine that activates cardiac slow delayed rectifier K+ currents","volume":"54","author":"Salata","year":"1998","journal-title":"Mol Pharmacol"},{"issue":"15","key":"10.1016\/j.ebiom.2024.105108_bib134","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.jacc.2018.01.078","article-title":"Interplay between genetic substrate, QTc duration, and arrhythmia risk in patients with long QT syndrome","volume":"71","author":"Mazzanti","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424001439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424001439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T07:44:27Z","timestamp":1738482267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424001439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":134,"alternative-id":["S2352396424001439"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105108","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impacts of gene variants on drug effects-the foundation of genotype-guided pharmacologic therapy for long QT syndrome and short QT syndrome","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105108","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105108"}}